A PHASE 2 STUDY TO ASSESS THE VIROLOGIC EFFICACY OF REGN10933+REGN10987 ACROSS DIFFERENT DOSE REGIMENS IN OUTPATIENTS WITH SARS-CoV-2 INFECTION

Administered By

Awarded By

Contributors

Start/End

  • December 21, 2020 - December 31, 2023